Markets move in cycles, some large, some small. 2021 saw a strong bullish trend, the strongest in decades; it was followed by a strong bearish trend, the strongest in decades, in 2022. This year opene...
Tag: Oppenheimer
Oppenheimer Says These 2 Stocks Have Double-Digit Gains in Sight
2023 is well underway now, and the key story is the sudden change in sentiment on the financial front. Last year’s bearish trend and headwinds are well known. Stubborn inflation, the Fed’s rapid incre...
Oppenheimer Suggests 2 Stocks to Buy, Including One With 170% Upside Potential
While the overall stock market direction so far this year remains up, the path ahead still presents plenty of potential headwinds. Inflation has yet to be properly tamed, the geopolitical map remains ...
Carvana Stock Could Become a ‘More Compelling’ Buyout Target, but Not Just Yet, Says Oppenheimer
To stave off any hostile takeover bids, on Tuesday Carvana (NYSE:CVNA) announced it has gulped down what is referred to as the “poison pill.” The used car dealer put into action a tax asse...
Coinbase Could Be One of Crypto’s Long-Term Survivors: Oppenheimer
According to him, if the U.S. Federal Reserve continues to raise interest rates, half of Coinbase’s revenue could be made up of the exchange’s subscription services, which are tied to a partnership wi...
Oppenheimer Says the S&P 500 Could Surge 15% in 2023 — Here Are 2 Stocks to Bet on It
The bear run of 2022 was brutal on stock investors, in fact, it was the worst market year since the Great Recession of 2008. But – some of the Street’s strategists are predicting that this year has a ...
Oppenheimer Suggests 3 Stocks to Buy
One thing is certain these days, and that’s uncertainty. Markets remain volatile, as a series of data releases have investors somewhat unsure whether high inflation, rising interest rates, or a possib...
Waiting for a Breakaway? Oppenheimer Says These 3 Stocks Are Poised to Lead Gains
Market conditions these days are best described as ‘unsettled.’ Inflation was lower in the October print, but remains stubbornly high, while the Fed’s reactive interest rate policy is pushing up the p...
This crypto stock could climb 80% despite FTX fiasco: Oppenheimer
Coinbase Global Inc (NASDAQ: COIN) down about 80% year-to-date remains a “buy” despite the recent FTX collapse, says Owen Lau. He’s a Senior Analyst at Oppenheimer. Coinbase is somewhat insulated to t...
‘History points to a post-midterm rally:’ Oppenheimer suggests 3 stocks to ride the momentum
America goes to the only poll that counts, and tomorrow morning we’ll have a better picture of the next Congress. All indications point toward a hefty GOP win, and a consequent legislative check on th...
Meaghan Oppenheimer Breaks Down The Finale
Jackson White and Grace Van Patten in ‘Tell me Lies’ on Hulu. Photo by Josh Stringer/Hulu. This article contains spoilers. You cannot say you weren’t warned! Hulu’s Tell Me Lies is one of ...
Oppenheimer Suggests 2 Stocks to Buy
This year we saw declines pretty much across the board, with the S&P 500 tumbling ~20%. But last week was the index’s best week since June – the S&P had a weekly gain of about 4.7%. We’ve seen...
Oppenheimer Suggests 2 Beaten-Down Stocks to Buy
The markets began the week with the best foot forward with all the major indexes charging ahead, but as evidence has shown throughout the year, that is no guarantee a sustained rally is in the cards. ...
Oppenheimer Likes These 2 Stocks for a Comeback Rally
The big question: Has the market hit a bottom yet? Well, according to Oppenheimer’s Head of Technical Analysis Ari Wald, there are signs one is forming, the most notable of which is that the Rus...
Meaghan Oppenheimer On Hulu’s ‘Tell Me Lies’: ‘Heartbreak Is Universal’
Grace Van Patten and Jackson White in ‘Tell Me Lies’ on Hulu. Photo by Josh Stringer/Hulu. There are few feelings as universal as heartbreak. We’ve all been there, whether it’s unrequited ...
Netflix shares could climb another 35%: Oppenheimer
Now is a good time to hop back into the Netflix Inc (NASDAQ: NFLX) stock, says Jason Helfstein. He’s a Managing Director at Oppenheimer. Netflix shares should be worth $325 Helfstein, on Monday, recom...
Oppenheimer Says Biotech Stocks Look a Bit Brighter Right Now; Here Are 2 Names to Consider
The biotech sector, like most sections of the market, took a sound beating in the year’s first half. Recently, however, the segment’s performance has improved, and that has helped the NASDAQ Biotechno...
‘The Market Bottom Is Near,’ Says Oppenheimer — Here Are 2 Stocks to Play That Bullish Sentiment
In a market trending down, there are fewer scenarios more appealing to investors than ones outlining bearish sentiment is about to turn positive. And according to Ari Wald, head of technical analysis ...
‘Trade With Caution,’ Says Oppenheimer; Here Are 2 Stocks to Consider
Fed Chair Jerome Powell’s comments regarding the central bank’s intention to curb inflation even if it causes “some pain” spooked the markets on Friday. And according to Ari Wald, He...
These 2 Penny Stocks Are Poised for a Big Rally, Says Oppenheimer
Does high risk mean high reward? Not necessarily, so say the pros on Wall Street. Specifically citing penny stocks, or stocks that trade for less than $5 per share, analysts advise caution as these na...
Oppenheimer Says S&P 500 Could Rise Another 12% by Year-End — and These Stocks Could Follow
July signed off with a bang, in what turned out to be the stock market’s best month since November 2020. Better-than-anticipated Q2 earnings from some of the world’s biggest companies alongside ...
Oppenheimer Sees Gains of 60% (Or More) in These 2 Beaten-Down Stocks
Second quarter earnings season is well under way, and it’s forming a positive counterpoint to a series of gloomy data releases expected this week. So far, some 100 or more of the S&P-listed ...
First Poster For Chris Nolan’s ‘Oppenheimer’ Arrives Right On Time
Poster for Chris Nolan’s ‘Oppenheimer’ Universal I have no idea (and wouldn’t tell you if I did) as to whether audiences showing up to Nope this evening will get an announcement teas...
Here are 2 stocks that Oppenheimer likes
By now, we all know the litany of market woes and headwinds: inflation, which has been grabbing all the headlines; the Fed’s turn to rate hikes and monetary tightening in response to inflation; the co...
These 2 Penny Stocks Have Over 300% Upside on the Horizon, Says Oppenheimer
Earlier this month, the S&P 500 officially entered a bear market; its current year-to-date loss stands at 21%, and the NASDAQ, which has fallen faster and farther, stands at a 30% ytd loss. The ra...
Oppenheimer Pounds the Table on Nvidia Stock
In an upbeat research note, Oppenheimer analyst Rick Schafer laid out the bull case for buying Nvidia (NVDA) stock — why he rates it “outperform” and expects Nvidia shares to nearly ...
Yes, Nvidia Stock is Expensive — But Oppenheimer Says It’s Worth the Price
In less than week — Wednesday, May 25 — Nvidia (NVDA) is due to report its Q1 2022 earnings. Analysts on average are optimistic about the report itself, and also about the guidance Nvidia ...
Coinbase Stock’s ‘Distress Level’ Offers a Long-Term Opportunity, Says Oppenheimer
Whether you’re a crypto fan or not, the industry never lacks for drama. The past week was particularly buzzy after the stablecoin TerraUSD de-pegged from the U.S. dollar and sent crypto prices tumblin...
EUA for Covid-19 Treatment Could Be Granted by Q3, Says Oppenheimer
Stocks are having a rough 2022, you say? Just have a chat with Veru (VERU) investors. Shares are up 125% on a year-to-date basis with almost half of the gains accrued over the past week. The uptick is...
The Bottom Is in for These 2 Stocks? Oppenheimer Says ‘Buy’
There’s really no use denying the headwinds that are pushing the markets around these days. Persistently high inflation, slowing GDP growth, and a jobs market that, while expanding in absolute terms, ...
Big Pharma Has Enough Cash to Buy All of Biotech. Why M&A Isn’t Happening.
Text size Late last year, Barron’s predicted a wave of deals, citing biotech companies’ cash holdings. Above, the plates used to print one-dollar bills. Alex Wong/Getty Images With biotech...
2 ‘Strong Buy’ Stocks Oppenheimer Sees Surging Over 80%
The markets went into bloodbath mode on Thursday as all the main indexes tumbled by at least 3%, with the NASDAQ’s 5% drop the most acute. That represented the tech-heavy index’s biggest one-day dive ...